NCT07803627

Brief Summary

The goal of this clinical trial is to evaluate how bladder filling affects the uterine flexion angle in adult nulliparous women with a uterine flexion angle \<90° when the bladder is empty. The main questions it aims to answer are: How does the uterine flexion angle change as bladder volume increases? What bladder volume is needed to obtain a uterine flexion angle \>90°? Participants will: Drink 600 mL of water following a standardized protocol. Undergo repeated suprapubic ultrasound measurements of bladder volume and uterine flexion angle. Remain under observation until urination or for a maximum of 4 hours. No comparison group is included in this study.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Sep 2026Mar 2027

First Submitted

Initial submission to the registry

August 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 3, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

September 15, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2027

Last Updated

September 3, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

August 28, 2026

Last Update Submit

September 2, 2026

Conditions

Keywords

Uterine anteflexionNulliparous womenBladder fillingUltrasound measurements

Outcome Measures

Primary Outcomes (1)

  • Uterine Flexion Angle Measured at Different Bladder Volumes in Nulliparous Women With an Anteverted Uterus and Baseline Uterine Flexion Angle <90°

    The relationship between bladder volume and the angle of uterine flexion, as determined from repeated ultrasound measurements in the participants.

    4 hours

Study Arms (1)

Ultrasonography pelvic

OTHER

Repeated ultrasound measurements, alternating between volume and angle of flexion, immediately following a hydration protocol and then bladder emptying.

Procedure: Ultrasonography, Pelvic

Interventions

Repeated ultrasound measurements, alternating between volume and angle of flexion, immediately following a hydration protocol and then bladder emptying.

Ultrasonography pelvic

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult woman
  • Nulliparous
  • Registered with a social security scheme
  • Uterine flexion angle \< 90°, empty bladder

You may not qualify if:

  • Pregnant woman
  • Woman wishing to become pregnant and currently trying to conceive
  • Primary amenorrhoea
  • Menopause
  • History of surgical termination of pregnancy
  • History of medical termination of pregnancy
  • History of hysterectomy
  • History of conisation
  • Absence of the uterus
  • Symptoms of urinary tract infection (gross haematuria, burning on urination, frequent urination)
  • Under legal guardianship (curatorship, trusteeship)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benoit CHIRON

Le Relecq-Kerhuon, 29480, France

Location

MeSH Terms

Interventions

High-Energy Shock Waves

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Central Study Contacts

Benoit CHIRON, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2026

First Posted

September 3, 2026

Study Start

September 15, 2026

Primary Completion (Estimated)

March 15, 2027

Study Completion (Estimated)

March 15, 2027

Last Updated

September 3, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available after the publication of result and ending fifteen years following the last visit of the last patient
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations